A new approach to restore vision using light-sensitive cells in the eye
A new strategy for vision restoration based on melanopsin transduction mechanisms
This study is exploring a new way to help people with certain eye diseases regain some vision by making special cells in the eye more sensitive to light, using a technique that involves a harmless virus, and it’s currently being tested in mice before it can be tried in humans.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10877146 on NIH RePORTER |
What this research studies
This research investigates a novel method to restore vision in patients with retinal diseases that cause irreversible photoreceptor degeneration. The approach focuses on enhancing the light sensitivity of specific retinal cells called intrinsically photosensitive retinal ganglion cells (ipRGCs) by accelerating the signaling mechanisms of a photopigment known as melanopsin. By using viral techniques to manipulate the components involved in melanopsin signaling, the researchers aim to improve the speed and effectiveness of light response, potentially allowing patients to regain some visual function. The study will utilize mouse models to test these new strategies before considering human applications.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with retinal diseases that have resulted in the loss of rods and cones but still retain some functioning ipRGCs.
Not a fit: Patients with retinal conditions that do not involve the preservation of ipRGCs or those with other unrelated vision impairments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that restore vision in individuals suffering from certain types of blindness.
How similar studies have performed: Previous research has shown promise in using similar approaches to enhance light sensitivity in retinal cells, indicating potential for success in this novel strategy.
Where this research is happening
Houston, United States
- Baylor College of Medicine — Houston, United States (Active)
Researchers
- Principal investigator: Jiang, Zheng — Baylor College of Medicine
- Study coordinator: Jiang, Zheng
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.